[Sign in] [Register]   

EIAab logo

EIAab news detail, please contact if you have any questions about online orders and payment.
The imbalance of IL-18/IL-18BP in patients with systemic juvenile idiopathic arthritis
Update time:2013-04-24 23:28:22   【 Font: Large  Medium Small


Systemic JIA (SJIA) is one subtype of juvenile idiopathic arthritis (JIA) that is a leading cause of short-term and long-term disability in children . Although SJIA repre-sents only 10% – 20% of all cases of JIA, it accounts for more than two-thirds of the mortality associated with this condition . The etiology and pathogenesis of SJIA remain unknown. Further understanding of SJIA pathogen-esis may facilitate new therapeutic approaches. Interleukin-18 (IL-18) was originally identified as an interferon gamma (IFN)-g-inducing factor, and IL-18 can induce INF- g production by splenocytes, hepatic lympho-cytes, and type 1T helper (Th1) cell clones . IL-18 levels have been shown to be abnormal in some inflammatory dis-eases and in autoimmune diseases. IL-18 expression has been reported to be up-regulated in lupus nephritis (LN),type 1 diabetes, and other autoimmune diseases . IL-18 binding protein (IL-18BP) is a circulating decoy receptor that binds to IL-18 with high affinity. IL-18BP can effi-ciently antagonize the biological activities of IL-18 . Experiments have shown that IL-18BP could prevent or at-tenuate the development of some autoimmune diseases .


Cited products
Source:Acta Biochim Biophys Sin      by O Chen, N Shan, X Zhu, et al
Hot Genes
ALCAM ACE KSR2 ASPRO C19orf80 Gdf5 Trap1a Atf2
Top Searches
Ubiquitin ELISA Ubiquitin-protein ligase metalloproteinase Asprosin TRAP1A Tumor necrosis vitamin d
Why choose EIAAB
Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
Further Information
About us Protein center Bank account Distributors Terms & Conditions Career

Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab